Bremerhaven, October 2025 - The CE-IVD-certified M371-Test for the diagnosis and follow-up of testicular germ cell tumours is now used in numerous laboratories. As clinical use increases, so does the need to continuously ensure the quality and precision of the test results.
To support laboratories in this endeavour mir|detect offers again in 2025 the M371 Proficiency Check . This laboratory comparison programme enables participating facilities to check their measurement results as part of an international comparison and prove their diagnostic performance.
Participating laboratories receive a test kit with all the necessary reagents and five synthetic samples for analysis under routine conditions. After successful participation, mir|detect awards a certificate that documents the diagnostic precision of the laboratory and serves as proof of quality for doctors and patients.
The aim of the programme is to promote a uniformly high quality in the use of M371-Test and to strengthen confidence in miRNA-based diagnostics in everyday clinical practice.
Further information can be found in the M371 Proficiency Check brochure (English).
Registration
Interested laboratories can register until 7th of November 2025 by e-mail with the subject "M371 Proficiency Check" to info@mirdetect.de register or use the contact form .
